These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22402706)

  • 1. Delayed preattentional functioning in early psychosis patients with cannabis use.
    Pesa N; Hermens DF; Battisti RA; Kaur M; Hickie IB; Solowij N
    Psychopharmacology (Berl); 2012 Aug; 222(3):507-18. PubMed ID: 22402706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations.
    Hermens DF; Ward PB; Hodge MA; Kaur M; Naismith SL; Hickie IB
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):822-9. PubMed ID: 20302901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of complex mismatch negativity (cMMN) elicited by a two-tone pattern paradigm in early-phase psychosis.
    Ells EML; Rudolph ED; Sculthorpe-Petley L; Abriel SC; Campbell DJ; Tibbo PG; Fisher DJ
    Biol Psychol; 2018 May; 135():128-135. PubMed ID: 29596955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auditory Mismatch Negativity and P300a Elicited by the "Optimal" Multi-feature Paradigm in Early Schizophrenia.
    Fisher DJ; Campbell DJ; Abriel SC; Ells EML; Rudolph ED; Tibbo PG
    Clin EEG Neurosci; 2018 Jul; 49(4):238-247. PubMed ID: 29502452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finding the missing-stimulus mismatch negativity (MMN) in early psychosis: altered MMN to violations of an auditory gestalt.
    Rudolph ED; Ells EM; Campbell DJ; Abriel SC; Tibbo PG; Salisbury DF; Fisher DJ
    Schizophr Res; 2015 Aug; 166(1-3):158-63. PubMed ID: 26072323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurophysiological biomarkers support bipolar-spectrum disorders within psychosis cluster.
    Kaur M; Battisti RA; Lagopoulos J; Ward PB; Hickie IB; Hermens DF
    J Psychiatry Neurosci; 2012 Sep; 37(5):313-21. PubMed ID: 22469054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mismatch negativity/P3a complex in young people with psychiatric disorders: a cluster analysis.
    Kaur M; Lagopoulos J; Ward PB; Watson TL; Naismith SL; Hickie IB; Hermens DF
    PLoS One; 2012; 7(12):e51871. PubMed ID: 23251645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD.
    Rydkjær J; Møllegaard Jepsen JR; Pagsberg AK; Fagerlund B; Glenthøj BY; Oranje B
    Psychol Med; 2017 Jan; 47(2):377-388. PubMed ID: 27776572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMN and P3a Elicited by a Novelty Oddball Paradigm Are Not Reduced in Early-Phase Psychosis.
    Riel H; Rudolph E; MacPhee C; Tibbo PG; Fisher DJ
    Neuropsychobiology; 2022; 81(6):506-515. PubMed ID: 36380625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
    Kaur M; Battisti RA; Ward PB; Ahmed A; Hickie IB; Hermens DF
    Schizophr Res; 2011 Aug; 130(1-3):203-9. PubMed ID: 21550211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic effects of cannabis use on the auditory mismatch negativity.
    Greenwood LM; Broyd SJ; Croft R; Todd J; Michie PT; Johnstone S; Murray R; Solowij N
    Biol Psychiatry; 2014 Mar; 75(6):449-58. PubMed ID: 23830666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects.
    Rentzsch J; Buntebart E; Stadelmeier A; Gallinat J; Jockers-Scherübl MC
    Schizophr Res; 2011 Aug; 130(1-3):222-7. PubMed ID: 21624823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration mismatch negativity and P3a in first-episode psychosis and individuals at ultra-high risk of psychosis.
    Atkinson RJ; Michie PT; Schall U
    Biol Psychiatry; 2012 Jan; 71(2):98-104. PubMed ID: 22000060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced P3a amplitudes in antipsychotic naïve first-episode psychosis patients and individuals at clinical high-risk for psychosis.
    Mondragón-Maya A; Solís-Vivanco R; León-Ortiz P; Rodríguez-Agudelo Y; Yáñez-Téllez G; Bernal-Hernández J; Cadenhead KS; de la Fuente-Sandoval C
    J Psychiatr Res; 2013 Jun; 47(6):755-61. PubMed ID: 23507048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced duration mismatch negativity in adolescents with psychotic symptoms: further evidence for mismatch negativity as a possible biomarker for vulnerability to psychosis.
    Murphy JR; Rawdon C; Kelleher I; Twomey D; Markey PS; Cannon M; Roche RA
    BMC Psychiatry; 2013 Feb; 13():45. PubMed ID: 23375130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automatic sensory information processing abnormalities across the illness course of schizophrenia.
    Jahshan C; Cadenhead KS; Rissling AJ; Kirihara K; Braff DL; Light GA
    Psychol Med; 2012 Jan; 42(1):85-97. PubMed ID: 21740622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Chronic Cannabis Use on Auditory Mismatch Negativity Generation in Schizophrenia Patients.
    Roser P; Pichler EM; Habermeyer B; Kawohl W; Juckel G
    Pharmacopsychiatry; 2019 Mar; 52(3):126-133. PubMed ID: 29506304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatch negativity in tobacco-naïve cannabis users and its alteration with acute nicotine administration.
    Impey D; El-Marj N; Parks A; Choueiry J; Fisher D; Knott VJ
    Pharmacol Biochem Behav; 2015 Sep; 136():73-81. PubMed ID: 26188167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mismatch negativity (MMN) as biomarker predicting psychosis in clinically at-risk individuals.
    Näätänen R; Todd J; Schall U
    Biol Psychol; 2016 Apr; 116():36-40. PubMed ID: 26542526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.